Effects of IL-12 on Human Ovarian Tumors Engrafted into SCID Mice
- 28 February 1999
- journal article
- Published by Elsevier in Gynecologic Oncology
- Vol. 72 (2) , 154-160
- https://doi.org/10.1006/gyno.1998.5239
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Antitumor Efficacy of Adenocarcinoma Cells Engineered to Produce Interleukin 12 (IL-12) or Other Cytokines Compared With Exogenous IL-12JNCI Journal of the National Cancer Institute, 1997
- Interleukin-12: An Immunoregulatory Cytokine Produced by B Cells and Antigen-Presenting CellsMethods, 1997
- Interleukin-12 Inhibits Angiogenesis Induced by Human Tumor Cell Lines In VivoJournal of Investigative Dermatology, 1996
- Molecular Mechanisms of Lymphocyte-Mediated Cytotoxicity and Their Role in Immunological Protection and Pathogenesis In VivoAnnual Review of Immunology, 1996
- Interleukin-12: A Proinflammatory Cytokine with Immunoregulatory Functions that Bridge Innate Resistance and Antigen-Specific Adaptive ImmunityAnnual Review of Immunology, 1995
- Antitumor Activity of Interleukin-12Clinical Immunology and Immunopathology, 1994
- Biologic Therapy in the Management of Refractory Ovarian CancerGynecologic Oncology, 1993
- Antitumor and antimetastatic activity of interleukin 12 against murine tumors.The Journal of Experimental Medicine, 1993